...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Percutaneous interventions in subclavian artery-to-contralateral subclavian vein 'necklace' hemodialysis grafts: experience in five patients.
【24h】

Percutaneous interventions in subclavian artery-to-contralateral subclavian vein 'necklace' hemodialysis grafts: experience in five patients.

机译:锁骨下动脉至对侧锁骨下静脉“项链”血液透析移植物的经皮干预:5例患者的经验。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To describe clinical outcomes of endovascular interventions in the setting of thrombosis or dysfunction of anterior chest wall ("necklace") arteriovenous (AV) hemodialysis grafts. MATERIALS AND METHODS: Eight percutaneous interventions (balloon angioplasty, pharmacologic thrombolysis, and mechanical thrombectomy) were performed in five patients with anterior chest wall AV grafts. Primary, assisted, and secondary patencies, as well as technical success and complication rates, were determined. RESULTS: The technical success rate of percutaneous interventions in re-establishing a normal blood flow pattern within the AV grafts was 100%. Primary patency ranged from one to 23 months (median, 5 months). Primary assisted patency and secondary patency were 36 months and 8 months, respectively, in two patients who underwent more than one intervention. Postintervention access patency ranged from 5 to 36 months (median, 9 months), whereas graft lifetime ranged from 12 to 45 months (median, 24 months). There were no complications related to revascularization procedures. CONCLUSION: Percutaneous interventions can be performed safely and effectively in anterior chest wall AV grafts. Technical success and long-term patency rates appear to be similar to those of percutaneous interventions in upper-extremity hemodialysis AV grafts.
机译:目的:描述在前胸壁(“项链”)动静脉(AV)血液透析移植物血栓形成或功能障碍的情况下进行血管内干预的临床结果。材料与方法:对5例胸前壁AV移植患者进行了八次经皮干预(气囊血管成形术,药物溶栓和机械血栓切除术)。确定了主要,辅助和次要通畅性,以及技术成功率和并发症发生率。结果:经皮介入治疗在AV移植物中重建正常血流模式的技术成功率为100%。主要通畅时间为1到23个月(中位数为5个月)。两名接受一次以上干预的患者的主要辅助通畅时间分别为36个月和8个月。干预后通畅时间为5到36个月(中位数为9个月),而移植物的寿命为12到45个月(中位数为24个月)。没有与血运重建手术有关的并发症。结论:可对前壁前房室静脉移植物安全有效地进行经皮干预。技术成功率和长期通畅率似乎与上肢血液透析AV移植的经皮干预相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号